Prevalence of Immunosuppression Among US Adults

JAMA. 2024 Mar 12;331(10):880-882. doi: 10.1001/jama.2023.28019.
No abstract available

Plain language summary

This analysis presents population prevalence estimates of immunosuppression among US adults using data from the 2021 National Health Interview Survey.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Health Surveys
  • Humans
  • Immune Tolerance
  • Immunocompromised Host*
  • Immunosuppression Therapy* / statistics & numerical data
  • Prevalence
  • Risk Factors
  • Surveys and Questionnaires
  • United States / epidemiology